PGIM Corporate Bond 10+ Year ETF
PCL · ETF
About PCL
- Issuer
- PGIM
- Expense ratio
- 0.25%
- Assets under management
- $71.80M
- Inception
- Aug 1, 2025
- Asset class
- Fixed Income
- Website
- pgim.com
PCL key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 1.05K
- Volume
- 13
- Open price
- $45.93
- High today
- $46.27
- Low today
- $46.27
- 52 Week high
- $51.31
- 52 Week low
- $45.01
PGIM Corporate Bond 10+ Year ETF (PCL) at a glance
PGIM Corporate Bond 10+ Year ETF (PCL) last traded at $46.27, with a price-to-earnings ratio of 0.00.
Volume so far is 13 shares, below the average of 1.05K shares a day.
Over the past year PGIM Corporate Bond 10+ Year ETF has ranged from $45.01 to $51.31, and now sits 20% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.